Showing results (1401-1410 of 1,823) with videos related to

Sort By:
Pageof 183
Transplantation and Cellular Therapy|October 1, 2025
Identification of Distinct Subtypes in Immune Tolerance after Hematopoietic Cell Transplantation Using the Prospective ABLE1.0 Pediatric Study CohortBernard Ng, Andrew C Harris, Sayeh Abdossamadi, et al.
Transplantation and Cellular Therapy|September 23, 2025
Expression of HLA-B*35 is Associated With an Increased Risk of CMV Viremia and Clinically Significant CMV Infection following PTCy-Based Hematopoietic Cell TransplantationJessica S Little, Kyle M Hebert, Donna S Neuberg, et al.
Transplantation and Cellular Therapy|October 14, 2020
Prophylactic Foscarnet for Human Herpesvirus 6: Effect on Hematopoietic Engraftment after Reduced-Intensity Conditioning Umbilical Cord Blood TransplantationNajla El Jurdi, John Rogosheske, Todd DeFor, et al.
Transplantation and Cellular Therapy|October 14, 2020
Specific Class I HLA Supertypes but Not HLA Zygosity or Expression Are Associated with Outcomes following HLA-Matched Allogeneic Hematopoietic Cell Transplant: HLA Supertypes Impact Allogeneic HCT OutcomesChristine Camacho-Bydume, Tao Wang, Jennifer A Sees, et al.
Transplantation and Cellular Therapy|December 9, 2022
Fatigue in Hematopoietic Cell Transplantation Survivors: Correlates, Care Team Communication, and Patient-Identified Mitigation StrategiesChristina K Ullrich, Kelsey K Baker, Paul A Carpenter, et al.
Transplantation and Cellular Therapy|October 2, 2020
Long-Term Follow-up of High-Dose Chemotherapy with Autologous Stem Cell Transplantation in Children and Young Adults with Metastatic or Relapsed Ewing Sarcoma: A Single-Institution ExperienceAnna B Pawlowska, Victoria Sun, George T Calvert, et al.
Transplantation and Cellular Therapy|October 3, 2020
Myeloablative Conditioning for Allogeneic Transplantation Results in Superior Disease-Free Survival for Acute Myelogenous Leukemia and Myelodysplastic Syndromes with Low/Intermediate but not High Disease Risk Index: A Center for International Blood and Marrow Transplant Research StudyNelli Bejanyan, Meijie Zhang, Khalid Bo-Subait, et al.
Transplantation and Cellular Therapy|October 5, 2020
Acute Graft-versus-Host-Disease Other Than Typical Targets: Between Myths and FactsJacopo Mariotti, Olaf Penack, Luca Castagna
Transplantation and Cellular Therapy|October 5, 2020
Clinical Outcomes in Patients with FLT3-ITD-Mutated Relapsed/Refractory Acute Myelogenous Leukemia Undergoing Hematopoietic Stem Cell Transplantation after Quizartinib or Salvage Chemotherapy in the QuANTUM-R TrialSiddhartha Ganguly, Jorge E Cortes, Alwin Krämer, et al.
Transplantation and Cellular Therapy|October 12, 2020
Hematopoietic Cell Transplantation: Practice Predictions for the Year 2023Nosha Farhadfar, Linda J Burns, Tatenda Mupfudze, et al.
Pageof 183